Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations

Alan L. Ho*, Irene Brana, Robert Haddad, Jessica Bauman, Keith Bible, Sjoukje Oosting, Deborah J. Wong, Myung Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin Harrington, Sung Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis WordenBinaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

133 Citations (Scopus)
29 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science